Fetal Hematopoietic Stem Cell Transplantation Fails to Fully Regenerate the B-Lymphocyte Compartment  by Ghosn, Eliver Eid Bou et al.
Stem Cell Reports
ArticleFetal Hematopoietic Stem Cell Transplantation
Fails to Fully Regenerate
the B-Lymphocyte Compartment
Eliver Eid Bou Ghosn,1,* Jeffrey Waters,1 Megan Phillips,1 Ryo Yamamoto,2,3 Brian R. Long,4 Yang Yang,1
Rachel Gerstein,5 Cheryl A. Stoddart,4 Hiromitsu Nakauchi,2,3 and Leonore A. Herzenberg1
1Department of Genetics, Stanford University, Stanford, CA 94305, USA
2Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA
3Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
4Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA
5Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655, USA
*Correspondence: eliverg@stanford.edu
http://dx.doi.org/10.1016/j.stemcr.2015.11.011
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYB cells are key components of cellular andhumoral immunity and, like all lymphocytes, are thought to originate and renew fromhemato-
poietic stem cells (HSCs). However, our recent single-HSC transfer studies demonstrate that adult bone marrow HSCs do not regenerate
B-1a, a subset of tissue B cells required for protection against pneumonia, influenza, and other infections. Since B-1a are regenerated by
transfers of fetal liver, the question arises as to whether B-1a derive from fetal, but not adult, HSCs. Here we show that, similar to adult
HSCs, fetal HSCs selectively fail to regenerate B-1a.We also show that, in humanizedmice, human fetal liver regenerates tissue B cells that
are phenotypically similar to murine B-1a, raising the question of whether human HSC transplantation, the mainstay of suchmodels, is
sufficient to regenerate humanB-1a. Thus, our studies overtly challenge the current paradigm thatHSCs give rise to all components of the
immune system.INTRODUCTION
The hematopoietic stem cell (HSC) is currently defined
by its ability to both self-renew and stably reconstitute
all components of the immune system, including eryth-
rocytes, myeloid cells, granulocytes, and lymphocytes.
The current paradigm posits that a single HSC, which
resides in the bone marrow (BM), gives rise to all compo-
nents of the immune system (Osawa et al., 1996). How-
ever, we recently showed that HSC isolated from adult
BM fail to fully reconstitute the lymphocyte compart-
ment in a murine model of HSC transplantation (Ghosn
et al., 2012). In essence, we showed that a single HSC
purified from adult BM and transplanted into irradiated
recipients selectively fails to reconstitute the subset of
tissue B cells known as B-1a (Ghosn et al., 2012). Simi-
larly, fate-mapping studies by others (Ginhoux et al.,
2010) have shown that tissue macrophages, such as
microglia and Langerhans cells, and some subsets of
T cells (Yoshimoto et al., 2012), originate independently
of HSCs.
Since the initial purification and characterization of mu-
rine HSCs in 1988 (Spangrude et al., 1988), the phenotype
and reconstitution potential of HSCs from both mice and
humans have been extensively studied. Currently HSCs
are widely used in human regenerative therapies to restore
immunity in irradiated or otherwise immune-compro-Stem Cemised patients (Czechowicz and Weissman, 2011; Liang
and Zuniga-Pflucker, 2015; Pasquini and Zhu, 2014). How-
ever, relatively little is known about the scope of this recon-
stitution, particularly with respect to subsets of myeloid
cells and lymphocytes (i.e., tissue B cells) that are not
readily detectable in blood.
Among lymphocytes, B cells are a key component of
both cellular and humoral immunity, serving both as an-
tigen-presenting cells and antibody-producing cells. In
adult mice, B cells are commonly divided into five func-
tionally distinct subsets: follicular (FO), marginal zone
(MZ), transitional, B-1b, and B-1a B cells. These subsets
specialize in the recognition of the various classes of anti-
gens and differ in mechanisms by which they elicit or
provide immune effector functions. For example, FO B
(also known as B-2) produce the well-described germinal
center, T-cell-dependent immune responses against pro-
tein antigens. In contrast, B-1a produce a rapid antibody
response to T-cell-independent type 2 antigens (mainly
lipids and polysaccharides) (Martin et al., 2001). B-1a are
also known to produce most of the ‘‘natural’’ antibodies
in serum that protect from influenza (Choi and Baum-
garth, 2008), pneumonia (Haas et al., 2005; Weber et al.,
2014), and other serious infectious diseases. Together,
the various B-cell subsets orchestrate a multi-component
antibody response that helps achieve broad protection
against infections.ll Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Authors 137
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Since B-1a largely develop in situ during fetal life
and are readily reconstituted in adult recipients by trans-
fers of fetal liver (Kantor and Herzenberg, 1993), the
question arises as to whether B-1a are reconstituted
by fetal liver LT-HSCs, which selectively lose this recon-
stitution capacity as animals mature to adults (Ghosn
et al., 2012). Alternatively, B-1a are reconstituted from
distinct HSC-independent progenitors that are pre-
dominant in fetal liver, but scarce in adult BM. Support
for this latter hypothesis, which views B-1a and FO B as
separately developing lineages, comes from recent
studies of fetal hematopoiesis (Kobayashi et al., 2014).
In essence, small but detectable numbers of B-1-restricted
progenitors were found in the fetal liver of HSC-deficient
transgenic mice (Cbfb/:Tek-GFP/Cbfb) (Kobayashi
et al., 2014), suggesting that, in this transgenic condi-
tion, B-1 can develop independently of HSCs. To date,
however, the potential of purified fetal liver LT-HSCs
transplants to regenerate B-1a in vivo has not been
tested.
Here, we resolve this issue by showing that, similar to
adult BM, fetal liver LT-HSCs effectively regenerate FO,
MZ, transitional, B-1b, and peripheral blood B cells but still
fail to regenerate B-1a. These findings provide further evi-
dence that B-1a emerge as a separate B-cell lineage that
develops independently of LT-HSCs. Consistent with these
findings, we show that fetal liver LT-HSCs also fail to recon-
stitute a key component of the B-1a repertoire (i.e., VH11),
which produce anti-phospholipid antibodies known to
promote housekeeping activities and prevent autoimmu-
nity (Behar and Scharff, 1988; Elkon and Silverman,
2012; Nguyen et al., 2015).
Together, these studies challenge the broadly accepted
paradigm that LT-HSCs can give rise to all components of
the immune system. We discuss these findings in light of
recent studies showing that this HSC-independent devel-
opmental strategy may also apply in other hematopoietic
lineages (Ginhoux et al., 2010; Schulz et al., 2012;
Yoshimoto et al., 2012). Furthermore, from a medical
standpoint, we call into question current human regener-
ative therapies in which HSC transplantation is used to
restore immunity in immune-compromised individuals,Figure 1. Fetal Liver LT-HSCs Provide Stable Long-Term Reconstit
(A) Experimental design.E15 livers were processed into single-cell su
RFP+ LT-HSCs were sorted and injected intravenously along with resc
(B) Gating strategy to purify fetal liver LT-HSCs (Lin–, C-KIThi, SCA-1h
Lineage–, SCA-1hi cells.
(C) Levels of blood chimerism (% RFP+ donor cells) in mice that receive
liver (E15), and 1.5 3 106 unsorted adult (>8 weeks old) BM. Rec
donor-derived B cells, T cells, erythrocytes, and myeloid-granulocyte
(D) Gating strategy identifying all major peripheral blood subsets de
recipient mice from three independent experiments.
Stem Ceand consider the probable shortcomings of an immune sys-
tem that lacks the B-1a cell subset.RESULTS
Fetal Liver LT-HSCs Provide Long-TermReconstitution
of All Major Peripheral Blood Subsets
The fetal site at which the first long-term (LT)-HSC emerges
is still greatly debated (Cumano et al., 2000; Lux et al.,
2008; Medvinsky and Dzierzak, 1996; Palis et al., 1999).
Nevertheless, most researchers agree that, regardless of
their origin, LT-HSCs migrate to the fetal liver at approxi-
mately embryonic day 11.5 (E11.5) (Kumaravelu et al.,
2002), where they greatly increase in number and initiate
hematopoiesis before finally migrating to the BM.
To purify the LT-HSCs from fetal liver for studies here, we
designed a new high-dimensional (Hi-D) fluorescence-acti-
vated cell sorting (FACS) panel with which we sorted
LT-HSCs as C-KIThi, SCA-1hi, CD150+, CD48–, CD41–,
CD45+, CD38+, CD34lo, and lineage-negative (Lin–) cells
negative or low for GR-1, NK1.1, CD11B, CD3, B220,
IL-7R, and TER-119 (Figures 1B and S1). The LT-HSC pheno-
type defined here identifies all of the detectable LT-HSCs in
the mouse, as demonstrated by several single-cell adoptive
transfer studies (Ghosn et al., 2012; Inlay et al., 2014; Kiel
et al., 2005; Kim et al., 2006; Osawa et al., 1996; Yama-
moto et al., 2013). Hence, to date this phenotype repre-
sents the most pure and undifferentiated HSC capable of
providing long-term multi-lineage reconstitution in irradi-
ated mice.
To facilitate subsequent identification of LT-HSCprogeny
in adoptive recipients, we isolated LT-HSCs from transgenic
mice expressing monomeric red fluorescent protein (RFP)
knocked into the Rosa26 locus (Ueno and Weissman,
2006). The RFP reporter is stably and ubiquitously ex-
pressed in all (>99%) hematopoietic cells, including fetal
liver LT-HSCs (Figures S2A and S2B). Since the phenotype,
percentage, and absolute number of the various hemato-
poietic cells (including B-cell subsets) are virtually identical
between TM7-RFP and C57BL/6 (Figures S2C and S2D), the
TM7-RFP strain provides a robust and reliable model withution of All Major Blood Subsets
spensions and stained as described in the Experimental Procedures.
ue RFP–GFP+ BM cells into lethally irradiated C57BL/6.
i, CD150+, CD48–, CD41–, CD45+) (see also Figure S1). KLS: C-KIThi,
d100 sorted fetal liver LT-HSCs (E15),1.53 106 unsorted fetal
ipient mice were bled several times to determine the percentage of
s.
rived from fetal liver LT-HSCs (RFP+). Data are representative of six
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which to study the reconstitution of the various B-cell sub-
sets by adoptively transferred LT-HSCs.
Six to 9 months after transplantation, more than 70%
of total red and white blood cells (including erythrocytes,
myeloid cells, granulocytes, Tcells, andBcells) in theperiph-
eral blood of recipientmice are derived from the donor-puri-
fied fetal liver LT-HSCs (Figure 1C). This high level of chime-
rism (>70%), obtained even 9months after transplantation,
confirms that the fetal liver LT-HSC studied here were fully
multi-potent, since theydemonstrated significantand stable
reconstitution for all of the major peripheral blood subsets
(Figure 1D). The levels of chimerism and long-term reconsti-
tution for the various subsets of blood cells were similar be-
tween recipients of sorted fetal liver LT-HSCs and unsorted
fetal liver and adult BM (>70%) (Figure 1C). These findings
are consistent with previous studies demonstrating that
the LT-HSC phenotype we use here marks all of the long-
term multi-lineage HSCs in these tissues (Ghosn et al.,
2012; Inlay et al., 2014; Kiel et al., 2005; Kim et al., 2006;
Osawa et al., 1996; Yamamoto et al., 2013).
Fetal Liver LT-HSCs Efficiently Reconstitute B-2 and
B-1b, but Selectively Fail to Reconstitute B-1a in
Periphery
To determine the potential of fetal liver LT-HSCs to recon-
stitute B-cell subsets in the periphery, particularly their
ability to reconstitute B cells that are not readily detectable
in blood, we harvested peritoneal cavity, spleen, and BM of
recipient mice 6–9 months after transplantation. To simul-
taneously identify several functionally distinct subsets of B
cells (i.e., FO, MZ, transitional, B-1a, and B-1b), we used
new 18-parameter FACS panels designed for each of the tis-
sues we analyzed.
Surprisingly, fetal liver LT-HSC transplantation failed
to reconstitute the resident peritoneal B-1a (CD5+ B cells).
In contrast, B-2 and B-1b cells were readily reconsti-
tuted in all recipients (Figures 2A–2C). Importantly, even
6–9 months after transplantation, when all hematopoietic
cells had stably developed and renewed in the peripheral
blood of recipient mice (Figure 2D), there were still no
B-1a detectable in the reconstituted mice.
Despite being unable to reconstitute B-1a, fetal liver LT-
HSCs reconstituted a substantial proportion of B-1b (Figures
2A–2C). This finding is quite surprising in light of the pre-
sumed close lineage relationship between B-1a and B-1b
cells. In essence, our findings place B-1b and B-2 cells in the
same developmental lineage, which derives from LT-HSCs.
Thus, B-1a is placed in a separate developmental pathway
that originates in fetal life independently of the fetal
(E15) liver LT-HSCs sorted and transferred in our studies.
To determinewhether the fetal liver CD150– fraction, un-
like CD150+CD48– LT-HSCs, can reconstitute B-1a cells, we
purified and transferred fetal liver KLS CD150– progenitor140 Stem Cell Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Autcells and compared their B-1a reconstitution potential
with that of total unsorted fetal liver. We show that KLS
CD150– progenitors reconstitute B-1a cells to the same
extent as unsorted fetal liver, suggesting thatmost B-1a pro-
genitors are contained within the CD150– fraction (Figures
2A–2C).Hence, the failure of LT-HSCs to reconstitute B-1a is
not due to a lack of support for B-1a development in the
adult recipient environment, as peritoneal B-1a are readily
reconstituted by both sorted CD150– fraction and unsorted
fetal liver, albeit at about half the normal level (i.e., this
reconstitution is statistically significantly less compared
with the numbers—absolute and relative—of B-1a cells ob-
tained from adult unmanipulatedmice) (Figures 2A–2C). In
addition, transfers of LT-HSCs purified from neonatal (day
0) or adult (>8 weeks) BM into neonatal (day 0) recipients
fail to reconstitute B-1a (Figures S3A and S3B), indicating
that the selective inability of LT-HSCs to reconstitute B-1a
reflects an intrinsic genetic program that excludes their
development to B-1a (rather than a response that is dictated
by the fetal/neonatal environment).
Similarly, when LT-HSCs from adult BM are co-trans-
ferred with unsorted fetal liver cells from congenic donors,
the BM LT-HSC do not reconstitute B-1a, even though the
co-transferred fetal liver readily reconstitutes B-1a (Fig-
ure S3C). Finally, earlier transfer studies have clearly shown
that B-1a are readily reconstituted when early progenitors
(fetal liver, neonatal spleen, and neonatal BM) are trans-
ferred into lethally irradiated adult recipients (Herzenberg
et al., 1992; Kantor and Herzenberg, 1993). Together, these
findings demonstrate that in an environment conducive to
B-1a development, fetal liver LT-HSC transplantation gives
rise to B-2 and B-1b cells, but do not give rise to B-1a.
Analysis of the BM of mice reconstituted with LT-HSCs
9 months after transplantation shows that fetal liver
LT-HSCs reconstitute all major hematopoietic lineages,
including KLS cells (C-KIThi, Lin–, SCA-1hi) (Inlay et al.,
2014), myeloid progenitors (Lin–, SCA-1–, C-KIThi, which
includes CMPs, GMPs, and MEPs) (Inlay et al., 2014),
lymphoid progenitors (Lin–, SCA-1+/hi, and C-KIT–/lo,
which includes IL-7R+ common lymphoid progenitors
[CLPs]) (Welner et al., 2008), and their respective differen-
tiated lineages (Lin+) (Figure 2E). Consistent with the high
levels of donor LT-HSC chimerism in peripheral blood in
these mice (Figure 2D), >90% of total BM cells, including
LT-HSCs, are derived from the transferred RFP+ fetal liver
transplants (Figure 2E).
Hence, although fetal liver RFP+ LT-HSC transplants fail
to reconstitute B-1a cells in the periphery, they are fully
capable of reconstituting and stably renewing all other
B-cell subsets (as well as other hematopoietic lineages).
Thus, we conclude that these latter BM-derived cells all
belong to a single, predominant, LT-HSC-derived hemato-
poietic lineage to which B-2 and B-1b, but not B-1a, belong.hors
Figure 2. Fetal Liver LT-HSCs Selectively Fail to Reconstitute B-1a in Peritoneal Cavity
(A) B-cell subsets from adult intact (unmanipulated) C57BL/6 were compared with B cells from mice that received RFP+ sorted fetal liver
LT-HSCs, unsorted fetal liver, and sorted fetal liver KLS CD150– transplants (E15 embryos). Total donor B cells (RFP+, CD19+) were
analyzed for the expression of CD5 and CD23 to identify B-1a (CD5+CD23–), B-1b (CD5–CD23–), and B-2 (CD5–CD23+).
(B) Percentage of B-cell subsets in PerC of mice that received sorted or unsorted fetal liver transplants compared with adult unmanipulated
C57BL/6. *p < 0.0001, **p = 0.001.
(C) Absolute numbers of B-1a cells in PerC of mice that received sorted or unsorted fetal liver transplants. *p < 0.0001, **p = 0.0009,
***p = 0.03. Error bars represent the mean and SD for B-cell numbers obtained from the fully chimeric recipient mice that showed the
highest levels of B-cell chimerism (six mice for LT-HSCs, seven mice for unsorted fetal liver, and four mice for KLS CD150–) from three
independent experiments. p Value for means comparison using Student’s t test, a = 0.05 (JMP; SAS Institute).
(D) Percentage of blood cell subsets (RFP+) detected in recipients 7.5 months after LT-HSC transplantation, when recipient PerC cells
were harvested.
(E) BM from recipient mouse7.5 months after transplantation. RFP– cells are derived from rescue BM co-transplanted with RFP+ LT-HSCs.
KLS: C-KIThi, Lineage–, SCA-1hi population enriched for LT-HSCs.Human Fetal Liver Transplants Reconstitute
Peritoneal B Cells that Resemble Murine B-1a
Important from a medical standpoint, we show that
transfers of human fetal liver (E20–24 gestational weeks)
into BLT (BM, liver, thymus) humanized mice readily givesStem Cerise to peritoneal B cells expressing a phenotype similar to
B-1a cells that are derived from mouse fetal liver trans-
plants (Figure S4). Thus, similar to murine fetal liver
(Figures 2 and S4), human fetal liver contains progenitors
for phenotypically distinct B-cell subsets, one of whichll Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Authors 141
Figure 3. Fetal Liver LT-HSCs Effectively Reconstitute FO and MZ B Cells, but Fail to Reconstitute B-1a in Spleen
(A) Splenic B-cell subsets in adult intact (unmanipulated) C57BL/6 compared with B cells that were reconstituted in mice that received
RFP+ sorted fetal liver LT-HSCs, unsorted fetal liver, and sorted fetal liver KLS CD150– transplants (E15 embryos). Live, single cells were
analyzed for the expression of CD5 and CD19 to identify T and B cells, respectively. Spleen from recipient mice were first gated on RFP+ to
(legend continued on next page)
142 Stem Cell Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Authors
expresses a phenotype similar to murine peritoneal B-1a
and specifically migrates to mouse peritoneal cavity in a
humanized mouse model (Figure S4). Although the defini-
tive phenotype and characterization for humanB-1a cells is
yet to be determined, our data clearly show that human
fetal liver transplants give rise to a subset of B cells that
migrate into the mouse peritoneal cavity and express a
phenotype similar to mouse peritoneal B-1a, raising the
likelihood that human B-1a develop independently of hu-
man fetal liver LT-HSCs.Fetal Liver LT-HSCs Efficiently Reconstitute FO, MZ,
and Transitional B Cells, but Fail to Reconstitute B-1a
in Spleen
Similar to the results from the peritoneal cavity (Figure 2),
fetal liver LT-HSCs failed to reconstitute splenic B-1a (Fig-
ure 3). All of the othermajor B-cell subsets are reconstituted
and stably renewed at normal proportions, comparable
with unmanipulated mice (Figure 3). Hence, except for
B-1a, B-cell development is essentially normal in mice
that received purified fetal liver LT-HSCs (Figure 3).Fetal Liver LT-HSC Transplantation Does Not Restore
the VH11 Anti-Phospholipid Repertoire, a Well-
Known Functional Component of B-1a
To further confirm the selective inability of the LT-HSC
to give rise to B-1a, we investigated the expression of the
IgHVH11 gene family (Figure 4), which is known to be
uniquely expressed by B-1a (Hardy et al., 2004). The VH11
antibody repertoire in wild-type mice is largely encoded by
germ-line sequences and shows little or no N-insertion
and/or mutation. B-1a expressing VH11 produce ‘‘natural’’
antibodies that react with the endogenous trimethyl-
ammonium group expressed on phosphatidylcholine and
sphingomyelin, phospholipids found in or on erythrocytes,
platelets, stomach, intestine, and circulating low-density li-
poprotein (Hardy et al., 2004; Poncet et al., 1990). Collec-
tively, these well-known B-1a autoantibodies are thought
to participate in ‘‘housekeeping’’ activities (Elkon and Silver-
man, 2012) that include the recognition and/or neutraliza-
tion of potentially deleterious autoantigens, some of which
have been implicated in autoimmune disease (Behar and
Scharff, 1988; Gronwall et al., 2012; Nguyen et al., 2015).include all progeny derived from the donor transplants. CD21 an
(CD21hiCD23–), FO (CD23hiCD21lo), and immature + B-1a (CD21lo/–CD2
(B) Percentage of B-cell subsets in spleen of mice that received sorted
C57BL/6. *p < 0.0001, **p = 0.001, ***p = 0.05.
(C) Absolute numbers of B-1a cells in spleen of mice that received sorte
0.05. Error bars represent the mean and SD for the B-cell numbers obta
levels of B-cell chimerism (six mice for LT-HSCs, seven mice for unsort
experiments. p Value for means comparison using Student’s t test, a
Stem CeConsistent with the inability of fetal liver LT-HSCs to give
rise to B-1a, we find that VH11-encoded B cells are virtually
absent in mice reconstituted with fetal liver LT-HSC
even 7 months after transplantation (Figure 4). Thus, the
absence of phenotypically identifiable B-1a in the reconsti-
tuted mice is supported by the absence of one of the key
functional B-1a subsets present in wild-type mice, indi-
cating that IgHVH11 variable region gene expression by
B cells is restricted to those generated by a separate develop-
mental pathway that gives rise to B-1a during late fetal and
early neonatal life.DISCUSSION
Here, we define a lineage of tissue B cells that originates
independently of the fetal liver LT-HSC. In essence we
show that, in a transplantation setting, fetal liver LT-
HSCs selectively fail to regenerate B-1a cells in otherwise
fully reconstituted hosts. These findings call into question
the current view that HSCs regenerate all components of
the immune system, a view of particular importance to
modern medicine, since HSC transplantation is broadly
used to restore immune function in patients in whom the
immune system has been compromised (Czechowicz and
Weissman, 2011; Liang and Zuniga-Pflucker, 2015; Pas-
quini and Zhu, 2014). Our data demonstrate that at least
two B-cell lineages overlap in development during
ontogeny and are independently renewed throughout
life. The B-2 lineage, which mainly gives rise to FO, MZ,
transitional, and B-1b B cells, originates and is continually
renewed by HSCs located in both fetal liver and adult BM.
In contrast, the B-1a lineage, which gives rise to B cells
located mainly in pleural and peritoneal cavities, omen-
tum, and spleen, originates in the fetus independently of
liver HSCs and persists independently via self-renewal
throughout life.
These developmental distinctions between the lineages
to which B-1a and B-2 belong, i.e., HSC-independent
versus HSC-dependent, likely reflect a deeper development
schism that transcends the development of all mammalian
hematopoietic lineages. In bothmice and humans, the first
source of hematopoietic cells found during ontogeny is
located extra-embryonically in the yolk sac, in an anatomicd CD23 expression levels on B cells (CD19+) distinguished MZ
3lo/–). B-1a were identified as CD5+B220lo/.
or unsorted fetal liver transplants compared to adult unmanipulated
d or unsorted fetal liver transplants. *p < 0.0001, **p = 0.03, ***p =
ined from the fully chimeric recipient mice that showed the highest
ed fetal liver, and four mice for KLS CD150–) from three independent
= 0.05.
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Figure 4. Anti-Phospholipid VH11 Antibody Repertoire Is Absent in Mice that Received LT-HSC Transplantation
(A) PerC cells from adult (unmanipulated) C57BL/6, and mice that received RFP+ sorted LT-HSCs and unsorted fetal liver (E15) were
stained for anti-VH11 in an 18-par Hi-D FACS panel. Cells were first gated on RFP+ to include all progeny derived from donor transplants.
Donor-derived B cells (RFP+, CD19+) were analyzed for the expression of surface VH11 and IGM. B cells expressing IGM VH11 repertoire form
a diagonal cluster in the FACS plot. Recipient mice were analyzed 7.5 months after transplantation.
(B) Percentage of VH11+IGM+ B cells in PerC of mice that received sorted (LT-HSCs) or unsorted fetal liver transplants compared to adult
unmanipulated C57BL/6. *p < 0.0001, **p = 0.0007. Error bars represent the mean and SD. p Value for means comparison using Student’s
t test, a = 0.05. Data are representative of the six recipient mice (in each group) that showed the highest levels of B-cell chimerism in three
independent experiments.region known as the blood islands (Lux et al., 2008;
Moore and Metcalf, 1970; Ueno and Weissman, 2006).
Fetal nucleated erythrocytes are the first hematopoietic
lineage to emerge within the blood islands at E7 (Palis144 Stem Cell Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Autet al., 1999), prior to and independent of the development
of HSCs. Similarly, tissue macrophages, such as brain mi-
croglia, epidermal Langerhans cells, and some subsets of
liver Kupffer cells, originate in the yolk sac at E8, priorhors
to the development of HSCs (Ginhoux et al., 2010; Schulz
et al., 2012). Animals deficient in HSCs normally generate
these tissue macrophages, despite their inability to recon-
stitute HSC-dependentmacrophages, such as those derived
from LY6-Chi monocytes (Hashimoto et al., 2013; Schulz
et al., 2012).
This initial wave of HSC-independent erythrocyte-
myeloid development in the yolk sac (Lux et al., 2008; Palis
et al., 1999) is immediately followed by an initial wave of
lymphopoiesis (Boiers et al., 2013; Yoshimoto et al., 2011,
2012). Recent studies, using Rag1-GFP reporter mice,
show that the earliest lymphomyeloid-primed progenitors
(Lin–C-KIT+RAG1GFP+IL7Ra+) can be detected in the yolk
sac at E9, prior to HSC development (Boiers et al.,
2013). Consistent with this finding, E9 yolk sac endothe-
lium can differentiate into B-1-restricted progenitors
in vitro, and reconstitute both B-1 and MZ B, but not B-2,
in adoptive transfer recipients (Yoshimoto et al., 2011).
Similarly, fetal T-cell progenitors have been reported to
originate autonomously in E9 yolk sac prior to the develop-
ment of HSCs (Yoshimoto et al., 2012). Taken together,
these studies suggest that HSC-independent hematopoiesis
occurs for the lymphoid, myeloid, and erythroid lineages.
We therefore propose that the development of HSC-inde-
pendent hematopoietic cells in early embryos reflects an
overall developmental strategy of the immune system,
which initiates the first waves of ‘‘primitive’’ hematopoietic
cells carrying evolutionarily conserved functions that are
distinct from the HSC-derived cell and functions of the
adaptive immune system operating in adults.
In this construction, B-1a are located in the initial
lymphoid development wave, alongside fetal T cells
(mostly gdT), microglia, Langerhans cells, and fetal nucle-
ated erythrocytes. At least a subset of HSC-independent
B-1a, we suggest, carries a pre-defined genetic program
that has been refined throughout evolution to ensure the
development of germ-line-encoded B-cell receptor (BCR)
repertoires that are likely indispensable for basic immune
functions and to promote homeostasis. The development
of these germ-line-encoded repertoires, such as the VH11
gene family described here, are strictly regulated, as they
show little to no mutation in their CDR3 sequences and
are represented in the B-1a compartment in all mouse
strains (Hardy et al., 2004; Kantor et al., 1995a). Ultimately,
the ability of these HSC-independent immune cells to self-
renew locally throughout adulthood (Hashimoto et al.,
2013; Kantor et al., 1995b) enables them to participate in
immune responses alongside HSC-dependent immune
cells. Thus, to fully understand immune responses in chil-
dren and adults, it is necessary to explore the mechanisms
by which primitive (HSC-independent) immune cells that
develop in fetal life contribute to the function of the
(HSC-dependent) immune system operating in adults.Stem CeAlthoughmost B-1a cells largely develop de novo in fetal
life and are maintained thereafter by self-renewal, some
develop de novo in neonatal and adult mice (Ghosn
et al., 2011; Gu et al., 1992; Holodick et al., 2009; Kantor
et al., 1995b; Montecino-Rodriguez et al., 2006). We and
others have shown that adult spleen (Ghosn et al., 2011)
and BM (Montecino-Rodriguez et al., 2006) contain B-1-
restricted progenitors (CD19+B220–/lo) that give rise to
B-1a and B-1b, but not B-2, in adoptive transfer recipients.
However, the developmental origin of these B-1-restricted
progenitors is largely unknown. A simple hypothesis is
that B-1-restricted progenitors emerge in fetal life prior to
and independent of LT-HSCs and are then maintained
throughout adulthood by self-renewal. Alternatively, B-1-
restricted progenitors emerge de novo in adults via an un-
known developmental pathway(s) that is independent of
LT-HSCs. In any event, the small number of B-1a that are
usually reconstituted by transfers of adult BM, as shown
in previous studies (Duber et al., 2009; Esplin et al., 2009;
Holodick et al., 2009; Kantor and Herzenberg, 1993),
must derive from ‘‘passenger’’ progenitor cells that accom-
pany the actual LT-HSC.
Previous study by Dorshkind’s group (Barber et al., 2011)
has tested the B-1 reconstitution potential for CLPs sorted
from BM of neonatal (<2.5 weeks) and adult (>8 weeks)
mice. The authors concluded that neonatal, but not adult,
BM CLPs have the potential to give rise to B-1a. Because
most CLPs are contained within the CD150– fraction, the
results from this early study corroborate our findings that
fetal liver CD150–, but not CD150+ LT-HSCs, has the poten-
tial to reconstitute B-1a cells. However, Barber et al. (2011)
also show that KLS CD150+ progenitors (enriched for
LT-HSCs) sorted from neonatal BM have the potential to
reconstitute B-1a, albeit at very low numbers. Given that
the study was performed by transferring large numbers of
heterogeneous KLS CD150+ progenitors, it is possible that
the small number of B-1a cells detected in the recipient
mice were derived from progenitor cells that accompanied
the actual LT-HSCs.
Therefore, our findings that highly purified LT-HSCs fail
to reconstitute B-1a cells, together with recent studies
showing that HSC-deficient mice can develop B-1a cells
(Kobayashi et al., 2014), suggest that at least some B-1a cells
are a separate B-cell lineage that develops from progenitors
expressing a phenotype similar to neonatal CLP and fetal
KLS population (i.e., CD150–), but independent of the
fetal liver LT-HSC pathway. In any event, the true origin
and developmental pathway of B-1a cells is yet to be
determined.
These insights into the HSC-independent versus HSC-
dependent immune cell reconstitution pathway in mice
can be expected to affect protocols used for HSC transplan-
tation in clinical settings. Over the past 45 years, HSCll Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Authors 145
transplantation has been widely used to treat patients with
cancers such as leukemias, lymphomas, and myelomas,
and to treat several immune-deficiency disorders, among
other diseases (Liang and Zuniga-Pflucker, 2015; Pasquini
and Zhu, 2014). In the United States alone, approximately
20,000 HSC transplantations are performed yearly (Pas-
quini and Zhu, 2014). The survival rate for most HSC trans-
plantation used to treat malignant diseases is only 50%
during the first few years after transplantation, and about
20% of all deaths after HSC transplantation are due to
infectious diseases post transplant (Pasquini and Zhu,
2014). Thus, our data here call for further investigation
on whether humans, like mice, generate immune cells
independently of HSCs andwhether these cells play critical
roles that help protect HSC-transplanted patients from sub-
sequent infectious diseases.
As we have suggested, the failure to reconstitute B-1a
may be a serious impediment, since B-1a were shown to
be necessary, for example, to protect against viral, bacterial,
and fungal pathogens, such as influenza virus (Choi and
Baumgarth, 2008), Streptococcus pneumoniae (Haas et al.,
2005; Weber et al., 2014), and Francisella tularensis (Yang
et al., 2012), among others. Moreover, B-1a secrete most
of the natural antibodies detected in serum of unimmu-
nized mice (Baumgarth et al., 2005; Gronwall et al.,
2012), which is known to provide a first line of defense
against viral (Ochsenbein et al., 1999) and bacterial (Haas
et al., 2005; Ochsenbein et al., 1999) infections. A role for
natural antibodies in protection from pneumonia has
been appreciated for some time now (Briles et al., 1981).
Knockout mice deficient in B-1a cells (CD19/) lack natu-
ral antibodies and, hence, are more susceptible to infec-
tions caused by S. pneumoniae (Haas et al., 2005). Natural
antibodies are also implicated in protection against pneu-
mococci in humans (Carsetti et al., 2005). B-1a cells also
generate innate response activator (IRA) B cells that pro-
duce both granulocyte-macrophage colony-stimulating
factor and immunoglobulin M (Rauch et al., 2012). IRA B
cells can protect against both microbial sepsis (Rauch
et al., 2012) and pneumonia (Weber et al., 2014). Therefore,
in therapeutic settings such as BM transplantation using
highly purified HSCs (Czechowicz and Weissman, 2011),
the lack of B-1a and natural antibodiesmay be detrimental.
The human equivalent of B-1 has recently been proposed
for human peripheral blood (Rothstein et al., 2013), but the
definitive phenotype of human tissue B-1a is yet to be fully
defined. In any event, it is reasonable to expect that the
functions provided by B-1a in mice are performed by the
human equivalent. In fact, as we show here, human fetal
liver transplants readily reconstitute B cells in the perito-
neal cavity of humanizedmice. These human-derived peri-
toneal B cells are phenotypically similar to murine perito-
neal B-1a. Importantly, given that B-1a is rarely detectable146 Stem Cell Reports j Vol. 6 j 137–149 j January 12, 2016 j ª2016 The Autin blood, our findings here suggest that the human equiv-
alent of B-1a are likely to be found to reside in peripheral
tissues, rather than circulating in human blood. It remains
to be determined whether, similar to mouse, LT-HSCs puri-
fied from human fetal liver fail to reconstitute the perito-
neal (rather than blood) B cells we identified here. If so,
the human equivalent of B-1a may also originate from a
development pathway that is independent of the LT-HSC.
Support for this hypothesis comes from several human
B-cell development (Rechavi et al., 2015; Sanz et al.,
2010), phenotyping (Rothstein et al., 2013; Sanz et al.,
2010) and BCR sequencing (Rechavi et al., 2015) studies,
which distinguish the B-cell development pathway in em-
bryos and young children from thewell-known pathway in
adults.
Collectively, the findings we have presented here lead us
to propose that the development of HSC-independent lin-
eages early in ontogeny represents an evolutionary strategy
that ensures the development of an immune system car-
rying unique functions that are evolutionarily conserved
and distinct from the functions of the adaptive immune
system operating in adults. In adults, HSC-independent
and HSC-dependent immune systems co-exist and must
collaborate to maintain homeostasis or resist infections.EXPERIMENTAL PROCEDURES
Mice and Tissue Preparation
C57BL/6 and B6.IgHa mice (8–10 weeks old) were purchased from
Jackson Labs or bred at Stanford. Transgenic mice expressing
enhanced green (pCx-eGFP) (Wright et al., 2001), or red (TM7-RFP)
(Ueno and Weissman, 2006) fluorescent protein were kindly
provided by the Weissman laboratory (Stanford). NSG mice
(NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ) were purchased from Jackson
Labs and used to generate BLT humanizedmice. Tissues from recip-
ient mice were processed, filtered, and resuspended using custom
RPMI-1640 deficient in biotin, L-glutamine, phenol red, riboflavin,
and sodium bicarbonate, and containing 3% newborn calf serum
(defRPMI).
Blood (200 ml) was harvested via tail vein into EDTA-containing
tubes. Peritoneal cavity (PerC) cells were harvested by injecting
6 ml of defRPMI into PerC. Spleens were mechanically disrupted
to obtain single-cell suspension. BM from femurs and tibias were
flushed with defRPMI using a 28-gauge syringe. Cells were filtered
over a 70-mm nylon filter and erythrocytes were lysed using ACK
buffer. Fetal livers were harvested from E15 timed pregnant
mice, digested at 37C for 30 min with 0.25% collagenase (Stem
Cell Technologies), then again using enzyme-free cell dissociation
buffer (Gibco). Liver cells were mechanically pushed through a
70-mm nylon filter to obtain single-cell suspensions.
Timed pregnancies were confirmed via post-coital plug and em-
bryonic ages were confirmed via microscopy. All the procedures
were approved by Stanford Animal Care and Use Committee and
are in compliance with Administrative Panel on Laboratory Ani-
mal Care guidelines.hors
18-Parameter High-Dimensional Flow Cytometry
Cells were resuspended at 100 3 106 cells/ml in defRPMI and
stained on ice for 30 min (or 60 min when staining for CD34)
with the following fluorochrome-conjugated monoclonal anti-
bodies (mAbs) in a 16-color, 18-parameter staining combination
(see Table S1 for clones and sources). In brief, for recipient spleen:
anti-CD23, CD5, CD19, CD93,NK1.1, GR-1, CD11B,CD21, CD43,
TCRdg, IGK (kappa), and IGL (lambda) light chains, and B220;
PerC: anti-Vd6.3/2, CD5, CD19, F4/80, NK1.1, IGM, IGK, VH11,
CD23, IA/IE (or IA-B), CD11B, and B220; BM: anti-SCA-1,
CD11A, CD38, CD41, CD150, CD3, GR-1, TER-119, NK1.1,
B220, CD34, CD48, CD117, IL7R, CD19; and blood: anti-TER-
119, CD5, B220, LY6C, GR-1, CD11B, NK1.1, and CD19.
Cells were stained on ice for 15 min with Qdot605- or BV711-
conjugated streptavidin to reveal biotin-coupled antibodies.
Stained cells were resuspended in 10 mg/ml propidium iodide (PI)
to exclude dead cells. When cells were fixed, amine-reactive dyes
were used to exclude dead cells.
Both GFP and RFP were detected concomitantly with the
reagents described above for a total of 18-parameter Hi-D FACS.
Cells were analyzed on Stanford Shared FACS Facility instruments
(BD LSRII). Data were collected for 0.2–3 3 106 cells and analyzed
with FlowJo (TreeStar). To distinguish autofluorescent cells from
cells expressing low levels of a particular surface marker, we estab-
lished upper thresholds for autofluorescence by staining samples
with fluorescence-minus-one control stain sets in which a reagent
for a channel of interest is omitted.
Sorting and Transfer
Fetal liver from E15 pCx-eGFP or TM7-RFP were processed as
described above and stainedwith the followingmAbs in a 15-color,
17-parameter staining combination: anti-SCA-1, CD38, CD150,
CD34, CD48, CD117, CD41, CD45, IL7R, CD135, CD19, and
lineage markers (Lin) anti-CD3, B220, NK1.1, GR-1, CD11B, and
TER-119 (Table S1).
Cellswere stained on ice for 15minwith BV711-conjugated strep-
tavidin to reveal biotin-coupled mAbs and resuspended in PI, to
exclude dead cells. RFP+ or GFP+ LT-HSCs were identified as Lin–,
C-KIThi, SCA-1hi, CD150+, CD48–, CD41–, CD34low, CD45+,
CD38+, IL-7R–, and CD135– (Figures 1 and S1). Sorted LT-HSCs
were resuspended in serum-free defRPMI and about 100 cells were
transferred intravenously into lethally irradiated (two doses of
4.25 Gy delivered 4 hr apart) C57BL/6 along with 2 3 105 BM
rescue cells from 8-week-old congenic mice (i.e., pCx-eGFP or
B6.IgHa). After 30+ weeks, recipient PerC, spleen, BM, and blood
cells were harvested and LT-HSC-derived B cells (RFP+ or GFP+)
were analyzedasdescribedabove.TodetermineB-cell reconstitution
potential for neonatal or adult BM LT-HSCs, BM from RFP+ or GFP+
mice were processed and stained as described for fetal liver. LT-
HSCs were sorted on Stanford Shared FACS Facility BD FACSAriaIII.
Chimerism
Lethally irradiated recipientswere injectedwithoneof the following
donor cells: unsorted fetal liver (1,5 3 106 cells), sorted fetal liver
LT-HSCs (100cells), and sorted fetal liverKLSCD150– (6000cells)
fromE15embryos.Donorcellswereharvested fromTM7-RFPmice
and transferred intravenously into irradiated C57BL/6 along withStem Ce2 3 105 adult BM rescue cells from congenic B6.IgHa or pCx-
eGFP. Co-transfer of the rescue cells is necessary to prevent the
lethally irradiatedmice from succumbing to anemia during the first
weeks after irradiation. It readily provides red and white blood cells
until the transferred LT-HSCs reconstitute all major blood cells.
Recipientmicewere bledweekly to determine the level of chime-
rism, which we defined as the percentage of cells derived from the
donor fetal liver LT-HSCs (RFP+) found among total blood cells
recovered from recipient mice. Here, we examined the recipient
mice that showed full, long-term stable chimerism (i.e., develop-
ment of all major hematopoietic lineages, including erythrocytes,
myeloid cells, granulocytes, Tcells, and B cells) andhad the highest
chimerism in the B-cell compartment (>50%–99%of total B cells in
blood derived from sorted RFP+ or GFP+ fetal liver LT-HSCs). All of
the reconstituted hematopoietic lineages from donor cells were
still readily detectable in recipient blood when the mice were
euthanized and tissues harvested at R33 weeks post transplanta-
tion. Eighteen mice received 100 purified RFP+ fetal liver LT-
HSC transplants, and six became fully chimeric and were analyzed
for the presence of B-1a cells. The data shown in the various figures
represent the six fully chimeric mice that received purified
LT-HSCs, and the FACS plots shown in each figure represent the
analysis from the same recipient mouse.Humanized Mice
Humanized BLTmicewere generated as described by Stoddart et al.
(2011). In brief, two 1-mm3 pieces of human fetal liver and one
1-mm3 piece of thymus (Thy/Liv) were implanted together under
the kidney capsule of 10-week-old female NSG mice. Three weeks
after Thy/Liv implantation, NSG mice were irradiated (225 cGy)
and injected 30 hr later with 2–103 105 CD34+ autologous human
fetal liver cells (20–24 gestational weeks) containing heteroge-
neous populations of hematopoietic progenitors, including
HSCs. 20–24 weeks after CD34+ injection, recipient PerC was pro-
cessed and stained with the following fluorochrome-conjugated
mAbs in a 16-color, 18-parameter staining combination: anti-
CD45, IGM, CD20, CD14, CD16, CD80, CD24, CD5, CD19,
B220, IGD, CD27, CD43, CD10, CD3, and CD38. Amine-reactive
dye was used to exclude dead cells (Table S1). Animal protocols
were approved by the Institutional Animal Care and Use Commit-
tee of the University of California, San Francisco.
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